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INTRODUCTION
Low-density lipoprotein (LDL) accumulation and oxidative modification in the subendothelium has been found to promote monocyte and lymphocyte recruitment, triggering atherosclerosis. LOX-1 is a scavenger receptor which was first identified in endothelial cells and subsequently found to be expressed by macrophages and smooth muscle cells (SMC) (1) . Upon ligand binding, LOX-1 activation leads to intracellular signaling which may cause the onset of cardiovascular events or accelerate the development of atherosclerosis: enhanced secretion of enzymes, such as matrix metalloproteases by endothelial cells, increased superoxide production leading to reduced nitric oxide levels, and transcription factor NF-kB activation (2).
LOX-1 is a type II membrane protein belonging to the C-type lectin family and it is composed of The OLR1 linkage disequilibrium (LD)1 polymorphism regulates the expression of loxin mRNA.
Macrophages of subjects with the "no risk" polymorphism have higher levels of mRNA as well as protein expression than macrophages of subjects carrying the risk haplotype.
Macrophages are the main source of resistin in humans. Resistin belongs to the family of resistinlike molecules known as "found in inflammatory zone" (FIZZ), and it has been implicated in the regulation of inflammation through NF-kB pathway activation (6).
The IVS4-14 A>G polymorphism of human OLR1 gene influences the transcription of the two isoforms LOX-1/LOXIN whose ratio could allow the identification of subjects who are at risk of cardiovascular disease. Subjects carrying the mutant G allele express less loxin than those with the wild type A allele.
The aim of the present work was to investigate how this polymorphism could influence serological markers of lipid metabolism, inflammation and cytokine production after LOX-1 activation.
METHODS
A cohort of 1658 subjects aged 45-64 years and living in the province of Asti (north-western Italy) was enrolled in a metabolic survey. The subjects were evaluated at the beginning of the study Characteristics of subjects who were included in the study and those who were not, did not significantly differ (data not shown) and were similar to these of the whole cohort. The following have been measured: weight, height, waist circumference, blood pressure, values of fasting glucose, insulin, total cholesterol, HDL-cholesterol (HDL-Chol), triglycerides (Tg), high-sensitivity Creactive protein (hs-CRP), nitrotyrosine total antioxidant status, resistin levels and IVS4-14 A>G polymorphism of human OLR1 gene (loxin).
We have studied only men in order to avoid any possible bias due to sex differences in serum resistin levels, which have been demonstrated to be higher in women.
Informed consent was signed from all participants, all procedures were in accordance with the Declaration of Helsinki and this study was approved by the local Ethical Committee.
Diabetes and impaired fasting glucose (IFG) were diagnosed according to published recommendations (7) Hypertension and cardiovascular disease were diagnosed in line with the National Cholesterol Education Program (Adult Treatment Panel III) (NCEP-ATP III) criteria (8) .
Genotyping for IVS4-14 A>G polymorphism of human gene OLR1 was performed with the loxin test (Technogenetics, Sesto San Giovanni, Italy) through polymerase chain reaction followed by electrophoresis on agarose gel. Allele frequencies were calculated by gene counting. Values were expressed as mean ± SD, unless otherwise specified.
ANOVA and the chi-square test were used to compare means for continuous variables or frequencies for discrete variables, respectively.
Multiple regression analyses were used to evaluate the associations among values of NT, resistin, TAS, and presence of G allele, after adjustment for age, BMI, smoking habits, baseline diabetes, hypertension and coronary artery disease.
RESULTS
We considered three groups of subjects according to their IVS4-14 A>G genotype. The IVS4-14 A>G genotypic distribution in this population was in Hardy-Weinberg equilibrium. The normal homozygous genotype (AA) had a frequency of 40.9 %, the mutant homozygous genotype (GG) had a frequency of 27.5 % and the heterozygous genotype (AG) had a frequency of 31.5%. The G allele frequency was 0.43. Physical activity level and dietary intakes did not differ among genotype groups. Table 1 shows the distribution of mean baseline resistin, NT and TAS levels among the IVS4-14 A>G genotypes. The mean resistin and NT values were significantly higher, while TAS was significantly lower in homozygous G allele carriers.
In a multiple regression model, resistin and NT values are significantly and directly associated with G allele, while TAS is inversely associated. This association kept significant after adjustment for age, BMI, smoking habits, presence of diabetes, hypertension and coronary artery disease at baseline ( Table 2 ).
DISCUSSION
Our data suggest a significant association between loxin polymorphism and plasma resistin, NT and TAS. No association was found with markers of lipid metabolism. Resistin belongs to the family of resistin-like molecules (RELMs), and it also known as "found in inflammatory zone" (FIZZ). In humans, macrophages and adipose tissue are the main source of resistin (6) . In human macrophages, resistin enhances secretion of pro-inflammatory cytokines, TNF-α and IL-12, and is able to induce the nuclear translocation of NF-κB transcription factor (6) which plays a key role in regulating the expression of proinflammatory genes including those for vascular adhesion molecules and MCP-1 (9) . Therefore, resistin may mediate the association between increased LOX-1 stimulation and the NF-κB-triggered pro-inflammatory and pro-oxidative states which predispose to the development of atherosclerosis (2) . The finding of higher circulating resistin levels in subjects carrying the G allele suggests a major uptake of ox-LDL by LOX-1-expressing macrophages, smooth muscle cells, and monocytes,. Altogether, these data suggest that in G allele carriers a higher amount of ox-LDL is up-taken by mononuclear cells, reinforcing the proinflammatory activation of macrophages and the release of resistin.
Our data also suggest the peroxynitrite production may mediate LOX-1-mediated pro-inflammatory We were unable to find a genotype-dependent increase in coronary artery disease or diabetes in our cohort of subjects over the entire period of follow-up, since our study did not have sufficient statistical power to detect differences between the groups owing to the low number of incident events. Nevertheless, we provided evidence for an involvement of loxin polymorphism in the LOX-1-regulated intracellular signaling towards a pro-inflammatory state in the endothelium.
In conclusion, our results suggest that loxin polymorphism is likely to play a role in the early stages of the atherosclerotic process and that increased resistin secretion characterizes the pro-oxidant state associated with enhanced ox-LDL uptake by LOX-1. This is a population-based study. Replication in other centers/populations is likely to be necessary, and future prospective studies are needed to determine whether resistin plays a role in the development of clinical atherosclerosis and if resistin antagonism may reduce the increased cardiovascular risk of LOX-1 mutated allele.
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